AstraZeneca PLC - Stock Based Compensation

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Millions.

The item "Stock-Based-Compensation" stands at 579.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2024, the lowest value since 12/31/2021.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -6.46 percent compared to the value the year prior.
The 1 year change in percent is -6.46.
The 3 year change in percent is 109.03.
The 5 year change in percent is 164.38.
The 10 year change in percent is 271.15.

The Serie's long term average value is 309.42 Million United States Dollars. It's latest available value, on 09/30/2024, is 87.13 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2012, to it's latest available value, on 09/30/2024, is +316.55%.
The Serie's change in percent from it's maximum value, on 12/31/2022, to it's latest available value, on 09/30/2024, is -6.46%.